Phase
Condition
Williams Syndrome
Vascular Diseases
Stress
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion criteria:
Established essential hypertension
Treated with amlodipine 5 mg monotherapy for at least 4 weeks
With uncontrolled BP defined as mean SBP = or > 145 mmHg assessed by OBPM
Signed written inform consent obtained prior to inclusion in the study Randomisation Criteria:
Mean SBP = or > 135 mmHg assessed by HBPM
Good compliance with the HBPM protocol defined as at least 12 correct measurementsperformed over the last 6 days of the first period of measurements
Creatinine clearance = or > 30 ml/min, determined by Cockroft formula
Exclusion
Exclusion criteria:
Mean SBP = or > 180 mm Hg and/or mean DBP = or > 110 mm Hg measured at doctor's officeat Visit 1
Known or suspected causes of secondary hypertension
Patients with bilateral artery stenosis, renal artery stenosis in a solitary kidney,renal transplant or only one functioning kidney
Know contraindications or hypersensitivity to either amlodipine or irbesartan or tothe combination or history of angioedema related to the administration of anangiotensin II receptor antagonist or any combination of the drugs used
Known type 1 diabetes
Know severe hepatic impairment alanine aminotransferase (ALT) or aspartateaminotransferase (AST) > 5 times the upper limit of normal or history or hepaticencephalopathy, esophageal varices, or portocaval shunt
Known severe renal impairment (creatinine clearance < 30 ml/mn)
Concomitant use of any other antihypertensive treatment
Administration of any other investigational drug within 30 days before inclusion
Inability to obtain a valid automatic BP measurement recording
Presence of any severe medical or psychological condition that, in the opinion of theinvestigator, indicate that participation in the study is not in the best interest ofthe patient
Presence of any other conditions (e.g.: geographical, social, etc) that would restrictor limit the patient participation for the duration of the study
Pregnant or breast feeding women
Women of childbearing potential unable or unwilling to use an acceptable method toavoid pregnancy for the entire study period The above information is not intended to contain all considerations relevant to a patient'spotential participation in a clinical trial.
Study Design
Connect with a study center
Sanofi-Aventis Investigational Site Number 07602
Campinas, 13059-900
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 076-005
Rio de Janeiro, 20551-030
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 07605
Rio de Janeiro, 20551-030
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 07604
São José, 88103-460
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 076-004
São Paulo, 04038-002
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 07604
São José, 88103-460
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 076-002
São Paulo, 05403-000
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 076-004
São Paulo, 04038-002
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 07601
São Paulo, 04025-011
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 07603
São Paulo, 05403-000
BrazilSite Not Available
Sanofi-Aventis Investigational Site Number 15202
Santiago,
ChileSite Not Available
Sanofi-Aventis Investigational Site Number 15203
Santiago,
ChileSite Not Available
Sanofi-Aventis Investigational Site Number 15204
Santiago,
ChileSite Not Available
Sanofi-Aventis Investigational Site Number 15205
Santiago,
ChileSite Not Available
Sanofi-Aventis Investigational Site Number 15206
Santiago,
ChileSite Not Available
Sanofi-Aventis Investigational Site Number 17003
Barranquilla,
ColombiaSite Not Available
Sanofi-Aventis Investigational Site Number 17004
Barranquilla,
ColombiaSite Not Available
Sanofi-Aventis Investigational Site Number 17002
Medellin,
ColombiaSite Not Available
Sanofi-Aventis Investigational Site Number 81803
Alexandria,
EgyptSite Not Available
Sanofi-Aventis Investigational Site Number 81804
Alexandria,
EgyptSite Not Available
Sanofi-Aventis Investigational Site Number 81801
Cairo,
EgyptSite Not Available
Sanofi-Aventis Investigational Site Number 81802
Cairo,
EgyptSite Not Available
Sanofi-Aventis Investigational Site Number 42202
Beirut,
LebanonSite Not Available
Sanofi-Aventis Investigational Site Number 42203
Beirut,
LebanonSite Not Available
Sanofi-Aventis Investigational Site Number 42204
Beirut,
LebanonSite Not Available
Sanofi-Aventis Investigational Site Number 42205
Beirut,
LebanonSite Not Available
Sanofi-Aventis Investigational Site Number 42206
Beirut,
LebanonSite Not Available
Sanofi-Aventis Investigational Site Number 48401
Durango, 34080
MexicoSite Not Available
Sanofi-Aventis Investigational Site Number 48402
Guadalajara, 44656
MexicoSite Not Available
Sanofi-Aventis Investigational Site Number 48403
Guadalajara, 44656
MexicoSite Not Available
Sanofi-Aventis Investigational Site Number 48404
Guadalajara, 44680
MexicoSite Not Available
Sanofi-Aventis Investigational Site Number 48406
Guadalajara, 44670
MexicoSite Not Available
Sanofi-Aventis Investigational Site Number 48405
Mexico, 06140
MexicoSite Not Available
Sanofi-Aventis Investigational Site Number 48407
Mexico, 07330
MexicoSite Not Available
Sanofi-Aventis Investigational Site Number 50401
Casablanca,
MoroccoSite Not Available
Sanofi-Aventis Investigational Site Number 50402
Marrakech,
MoroccoSite Not Available
Sanofi-Aventis Investigational Site Number 50403
Marrakech,
MoroccoSite Not Available
Sanofi-Aventis Investigational Site Number 78804
Ariana,
TunisiaSite Not Available
Sanofi-Aventis Investigational Site Number 78803
Monastir, 5000
TunisiaSite Not Available
Sanofi-Aventis Investigational Site Number 78802
Sfax,
TunisiaSite Not Available
Sanofi-Aventis Investigational Site Number 78801
Tunis,
TunisiaSite Not Available
Sanofi-Aventis Investigational Site Number 86201
Caracas,
VenezuelaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.